Status:
TERMINATED
Continuous Glucose Monitoring (CGM) in Kidney-Transplanted Adults
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Diabetes Mellitus
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pre-existing diabetes prior KT and Early Post-Transplant Hyperglycemia (PTRH) defined as a fasting blood glucose greater than or equal to 126 mg/dL or random glucose greater than or equal to 200 mg/dL...
Detailed Description
Diabetes is a leading cause of end-stage renal disease, which is treated by undergoing kidney transplantation. Glycemic control post-transplantation is complicated for the diabetic population by a com...
Eligibility Criteria
Inclusion
- patients older than 18 years
- patients with history of diabetes (either T1D, T2D or atypical diabetes forms)
- patients could be on insulin or not before transplantation
Exclusion
- kidney-pancreas transplanted participants
- not currently using CGM (but could have used a year prior the transplant)
- mental conditions that prevent continuing with the study.
Key Trial Info
Start Date :
April 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2024
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT05352230
Start Date
April 15 2023
End Date
May 20 2024
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB Hospital
Birmingham, Alabama, United States, 35294